Copyright: ©Author(s) 2026.
World J Crit Care Med. Sep 9, 2026; 15(3): 120840
Published online Sep 9, 2026. doi: 10.5492/wjccm.120840
Published online Sep 9, 2026. doi: 10.5492/wjccm.120840
Table 1 Triggers for secondary haemophagocytic lymphohistiocytosis
| Infective triggers | Non-infective triggers |
| Viral | Auto-immune diseases, Crohn disease, sJIA, adult-onset Still’s disease, systemic lupus erythematosus, rheumatoid arthritis, systemic vasculitides, polymyositis, dermatomyositis |
| Epstein-Barr virus | |
| HIV | |
| Parvovirus B19 | |
| CMV, HSV, HHV-6, VZV | |
| Adenovirus | |
| SARS-Cov-2 virus | |
| Influenza A and B | |
| Dengue virus | |
| Bacterial | Malignancy related, lymphomas, monoclonal antibodies therapy, CAR-T therapies, ibrutinib |
| Mycobacteria spp. | |
| Rickettsia spp. | |
| Legionella spp. | |
| Staphylococcus spp. | |
| Escherichia coli | |
| Protozoan | Hematopoietic stem cell transplantation, solid organ transplantation |
| Leishmania spp. | |
| Plasmodium spp. | |
| Toxoplasma spp. | |
| Fungal | Drug-induced: Anticonvulsivants (lamotrigine, phenytoin, carbamazepine), antimicrobials (penicillins, cephalosporines), alemtuzumab |
| Histoplasma | |
| Pneumocystis jiroveci | |
| Candida spp. | |
| Aspergillus spp. | |
| Sepsis |
- Citation: Nedel W. Hemophagocytic lymphohistiocytosis in critically ill patients: A guide for clinicians. World J Crit Care Med 2026; 15(3): 120840
- URL: https://www.wjgnet.com/2220-3141/full/v15/i3/120840.htm
- DOI: https://dx.doi.org/10.5492/wjccm.120840